Cerebrospinal fluid concentrations of leukotriene B4 in bacterial meninigitis

Acta Paediatrica, International Journal of Paediatrics

Volumn 85, Issue 8, 1996, Pages 902-905

  Santer, R ^a,b   Sievers, E ^a   Schaub, J ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Cerebrospinal fluid; Leukotriene B4; Meningitis

Indexed keywords

LEUKOTRIENE B4;

ARTICLE; ASEPTIC MENINGITIS; BACTERIAL MENINGITIS; CEREBROSPINAL FLUID LEVEL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFANT; MALE; MENINGITIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0030390615     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1996.tb14181.x     Document Type: Article

References (19)

1. Sáez-Llorens X, Ramilo O, Mustafa MM, Mertsola J, McCracken GH. Molecular pathophysiology of bacterial meningitis: current concept and therapeutic implications. J Pediatr 1940;116:671-83
2. Mustafa MM, Lebel MH, Ramilo O, Olsen KD, Reisch JS, Beutler E. et al. Correlation of interletikin-1β and cachectin concentrations in cerebrospinal fluid and outcome from bacterial meningitis. J Pediatr 1989;115:208-13
3. Arditi M, Manogue KR, Caplan M, Yoger R. Cerebrospinal fluid cachectin/tumor necrosis lactor-α and platelet-activating factor concentrations and severity of bacterial meningitis in children. J Infect Dis 1990;162:139-47
4. Waage A, Halsteusen A, Espevik T. Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1987;1:355-7
5. Lebel MH, Freij BJ, Syrogiannopoulos GA, Chrane DT, Hoyt MJ, Stewart SM. et al. Dexamethasone therapy for bacterial meningitis: results of two double-blind, placebo controlled trials. N Engl J Med 1988;319:964-71
6. Odio CM, Faingezicht I, Paris M, Nasser M, Baltodano A, Rogers J. et al. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med 1991;324:1525-31
7. Schaad UB, Lips U, Gnehm HE, Blumberg A, Heinzer I, Wedgwood J. Dexamethasone therapy for bacterial meningitis in children. Lancet 1993;342:457-61
8. Mayatepek E, Hoffmann GF. Leukotrienes: biosynthesis, metabolism, and pathophysiologic significance. Pediatr Res 1995;37:1-9
9. Ohga S, Aoki T, Okada K, Akoda H, Fujidea K, Ohshima A. et al. Cerebrospinal fluid concentrations of interleukin-1β, tumour necrosis factor-α, and interferon gamma in bacterial meningitis. Arch Dis Child 1994;70:123-5
10. Mustafa MM, Ramilo O, Sáez-Llorens X, Olsen KD, Magness RR, McCracken GH. Cerebrospinal fluid prostaglandins. interleukin 1β, and tumor necrosis factor in bacterial meningitis. Am J Dis Child 1990;114:883-7
11. Matsuzono Y, Narita M, Akutsu Y, Togashi T. Interleukin-6 in cerebrospinal fluid of patients with central nervous system infections. Acta Paediatr 1995;84:879-83
12. van Furth AM, Steenwijk TM, Langermans JAM, van Furth R. In vitro effect of dexamethasone. pentoxifylline. and antiendotoxin monoclonal antibody on the release of proinflammatory mediators by human leukocytes stimulated with haemophilus influenzae type B. Pediatr Res 1994;35:725-8
13. Hynes N, Bishai I, Lees J, Coceam F. Leukotrienes in brain: natural occurrence and induced changes. Brain Res 1991;553:4-13
14. Black KL, Hoff JT. Leukotrienes increase blood-brain barrier permeability following intraparenchymal injections in rat. Ann Neurol 1985;18:349-5 1
15. + conductance inhibitor. Brain Res 1993;612:28-34
16. 4. Brain Res 1993;628:313-6
17. Sáez-Llorens X, Ramilo O, Mustafa MM, Mertsola J, de Alba C, Hansen E, et al. Pentoxyfylline modulates meningeal inflammation in experimental bacterial meningitis. Antimicrob Agents Chemother 1990;34:837-43
18. Tuomanem E, Hengstler B, Rich R, Bray MA, Zak O. Nonsteroidal anti-inflammatory agents in the therapy for experimental pneumococcal meningits. J Infect Dis 1987;155:985-90
19. 2 levels in cerebrospinal fluid in experimental pneumococcal meningitis in rabbits. Pediatr Infect Dis J 1987;6:1151-3